Indian journal of urology : IJU : journal of the Urological Society of India · 2026
Comparison between spectra modes of STORZ professional image enhancement system™ and white light cystoscopy in diagnosis of bladder lesions.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vinayak Kunal, Kotwal Subhash V, Kaushik Vikram B
Аннотация
INTRODUCTION: White light cystoscopy (WLC) often fails to detect flat or subtle bladder lesions. Enhanced imaging techniques offer improved detection. The Storz Professional Image Enhancement System (SPIES™) overcomes these limitations and enables concurrent display of WLC and enhanced images, potentially improving tumor detection. In this study, the SPIES™ system was integrated into the diagnostic cystoscopy protocol to compare Spectra™ modes with conventional WLC in the diagnosis of bladder lesions.
METHODS: This 1-year prospective observational pilot study included 150 patients with suspected or known bladder tumors. Each patient initially underwent WLC, followed by Spectra B™ and Spectra A™ modes. Lesions were mapped according to EAU guidelines; suspicious areas were biopsied or resected for histopathological analysis.
RESULTS: WLC showed a sensitivity of 96% and specificity of 45%, with a false positive rate (FPR) of 54.5%. After WLC, Spectra B did not detect any additional lesions, whereas Spectra A identified three additional lesions, including a T2 recurrence. Spectra A™ had 100% sensitivity, but lower specificity (35%) and higher FPR (65%). Spectra A™ detected more lesions than WLC, although the difference was not statistically significant (P = 0.131). The increase in FPR of the Spectra A™ was significant (P = 0.04).
CONCLUSIONS: Spectra A™ showed higher sensitivity and identified additional cancerous lesions, including one muscle-invasive tumor missed by WLC. However, it also had a significantly higher FPR. While promising, it has its limitations. Spectra A™ shows potential and warrants further research in larger, multicenter trials.
METHODS: This 1-year prospective observational pilot study included 150 patients with suspected or known bladder tumors. Each patient initially underwent WLC, followed by Spectra B™ and Spectra A™ modes. Lesions were mapped according to EAU guidelines; suspicious areas were biopsied or resected for histopathological analysis.
RESULTS: WLC showed a sensitivity of 96% and specificity of 45%, with a false positive rate (FPR) of 54.5%. After WLC, Spectra B did not detect any additional lesions, whereas Spectra A identified three additional lesions, including a T2 recurrence. Spectra A™ had 100% sensitivity, but lower specificity (35%) and higher FPR (65%). Spectra A™ detected more lesions than WLC, although the difference was not statistically significant (P = 0.131). The increase in FPR of the Spectra A™ was significant (P = 0.04).
CONCLUSIONS: Spectra A™ showed higher sensitivity and identified additional cancerous lesions, including one muscle-invasive tumor missed by WLC. However, it also had a significantly higher FPR. While promising, it has its limitations. Spectra A™ shows potential and warrants further research in larger, multicenter trials.